Search

Displaying results 6731 - 6740 of 8967 in total
  1. Drug

    Avotermin

    go.drugbank.com/drugs/DB11955
    Investigational

    Juvista has been investigated for the treatment, prevention, and basic science of Scars, Keloid, and Cicatrix.

  2. Drug

    Bradykinin

    go.drugbank.com/drugs/DB12126
    Investigational

    Bradykinin has been investigated for the basic science and treatment of Hypertension and Diabetes Type 2.

  3. Drug

    AZD-2836

    go.drugbank.com/drugs/DB06031
    Investigational

    [A264853] The drug is being investigated for treatment of hepatitis C because AZD-2836 has in vitro anti-HCV activity.[A264858]

  4. Drug

    Stepronin

    go.drugbank.com/drugs/DB01423
    Experimental

    A mucolytic agent is any agent which dissolves thick mucus usually used to help relieve respiratory difficulties.

  5. Drug

    Brilacidin

    go.drugbank.com/drugs/DB12997
    Investigational

    Brilacidin is under investigation for the supportive care of Mucositis, Stomatitis, Mouth Diseases, and Head and Neck Neoplasms.

  6. Drug

    OPC1

    go.drugbank.com/drugs/DB17944
    Experimental

    OPC1 is an oligodendrocyte progenitor cell therapy being investigated for the treatment of acute spinal cord injury.[L47082]

  7. Drug

    PMC-403

    go.drugbank.com/drugs/DB18132
    Investigational

    PMC-403 is a novel Tie2-activating antibody being investigated for the treatment of systemic capillary leak syndrome.

  8. Drug

    Ibezapolstat

    go.drugbank.com/drugs/DB16189
    Investigational

    Ibezapolstat is under investigation in clinical trial NCT04247542 (ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection).

  9. Drug

    Prosetin

    go.drugbank.com/drugs/DB18649
    Investigational

    Prosetin is an orally administered blocker of MAP4K under investigation for the treatment of amyotrophic lateral sclerosis.[L48360]

  10. Drug

    Rovaleucel

    go.drugbank.com/drugs/DB18691
    Investigational

    Rovaleucel is an EBV-specific autologous T-cell therapy under investigation for the treatment of EBV-positive cancers.